| 26/10/22 | 07:00:04 | 26 Oct 2022 | | UK Approval of genesig® SARS-CoV-2 Winterplex® 3G |
| 03/10/22 | 15:30:01 | 3 Oct 2022 | | Liquidity Agreement and Total Voting Rights |
| 29/09/22 | 07:00:12 | 29 Sept 2022 | | Half year 2022 results |
| 15/09/22 | 07:00:14 | 15 Sept 2022 | | Notice of Results and Investor Presentation |
| 01/09/22 | 12:00:06 | 1 Sept 2022 | | Liquidity Agreement and Total Voting Rights |
| 04/08/22 | 07:00:09 | 4 Aug 2022 | | Launch of first fully lyophilised PROmate® assays |
| 01/08/22 | 14:30:01 | 1 Aug 2022 | | Liquidity Agreement and Total Voting Rights |
| 28/07/22 | 07:00:18 | 28 Jul 2022 | | Launch of research-use-only adenovirus F41 assay |
| 20/07/22 | 15:00:05 | 20 Jul 2022 | | Results of AGM |
| 15/07/22 | 07:00:06 | 15 Jul 2022 | | Director/PDMR Shareholding |
| 15/07/22 | 07:00:05 | 15 Jul 2022 | | Approval of exsig™ COVID-19 Direct test in the UK |
| 07/07/22 | 15:00:06 | 7 Jul 2022 | | Director/PDMR Shareholding |
| 07/07/22 | 07:00:09 | 7 Jul 2022 | | Trading update and progress against strategy |
| 05/07/22 | 11:45:05 | 5 Jul 2022 | | Holdings in Company |
| 01/07/22 | 12:30:05 | 1 Jul 2022 | | Liquidity Agreement and Total Voting Rights |
| 28/06/22 | 07:00:10 | 28 Jun 2022 | | Launch of monkeypox assay |
| 21/06/22 | 14:00:03 | 21 Jun 2022 | | Notice of rescheduled AGM |
| 16/06/22 | 07:00:05 | 16 Jun 2022 | | DHSC dispute update |
| 13/06/22 | 07:00:07 | 13 Jun 2022 | | AGM Voting |
| 01/06/22 | 13:00:02 | 1 Jun 2022 | | Liquidity Agreement and Total Voting Rights |
| 01/06/22 | 07:00:10 | 1 Jun 2022 | | CTDA approval and CE mark |
| 01/06/22 | 07:00:10 | 1 Jun 2022 | | Publication of Annual Report and AGM voting |
| 13/05/22 | 07:00:04 | 13 May 2022 | | Notice of Annual General Meeting |
| 03/05/22 | 12:21:24 | 3 May 2022 | | Liquidity Agreement Update and Total Voting Rights |
| 28/04/22 | 07:00:12 | 28 Apr 2022 | | Full year results and update on growth strategy |
| 26/04/22 | 07:00:14 | 26 Apr 2022 | | DHSC dispute update |
| 20/04/22 | 07:00:05 | 20 Apr 2022 | | Notice of Results and Investor Presentation |
| 12/04/22 | 07:00:05 | 12 Apr 2022 | | Approval of COVID-19 test under CTDA legislation |
| 01/04/22 | 11:45:04 | 1 Apr 2022 | | Liquidity Agreement Update and Total Voting Rights |
| 25/03/22 | 17:25:08 | 25 Mar 2022 | | Director/PDMR Shareholding |
| 18/03/22 | 18:00:01 | 18 Mar 2022 | | Director/PCA Dealing |
| 15/03/22 | 14:30:01 | 15 Mar 2022 | | Director/PDMR Shareholding |
| 11/03/22 | 08:00:01 | 11 Mar 2022 | | Holdings in Company |
| 01/03/22 | 13:00:01 | 1 Mar 2022 | | Liquidity Agreement Update and Total Voting Rights |
| 18/02/22 | 16:05:03 | 18 Feb 2022 | | Holdings in Company |
| 17/02/22 | 07:00:08 | 17 Feb 2022 | | Approval of COVID-19 test under CTDA legislation |
| 15/02/22 | 16:00:06 | 15 Feb 2022 | | Holdings in Company |
| 04/02/22 | 07:00:04 | 4 Feb 2022 | | Long Term Incentive Plan |
| 01/02/22 | 14:30:09 | 1 Feb 2022 | | Liquidity Agreement and Total Voting Rights |
| 25/01/22 | 07:00:05 | 25 Jan 2022 | | Strategy and Full Year 2021 Trading Update |
| 04/01/22 | 16:30:08 | 4 Jan 2022 | | Liquidity Agreement and Total Voting Rights |
| 01/12/21 | 14:30:06 | 1 Dec 2021 | | Total Voting Rights |
| 26/11/21 | 07:00:06 | 26 Nov 2021 | | Approval of COVID-19 test under CTDA legislation |
| 02/11/21 | 07:00:03 | 2 Nov 2021 | | Validation of COVID-19 tests in the UK under CTDA |
| 01/11/21 | 17:30:02 | 1 Nov 2021 | | Liquidity Agreement and Total Voting Rights |
| 19/10/21 | 16:15:06 | 19 Oct 2021 | | Results of annual general meeting |
| 01/10/21 | 14:30:02 | 1 Oct 2021 | | Total Voting Rights |
| 30/09/21 | 07:00:11 | 30 Sept 2021 | | R&D update |
| 29/09/21 | 17:00:07 | 29 Sept 2021 | | Notice of AGM |
| 29/09/21 | 07:00:10 | 29 Sept 2021 | | Notice of rescheduled AGM |
